Viking Therapeutics, Inc.VKTXNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Recovery in Progress
Trending higher, below historical average, modest growth trend.
Left:
||||
Year-over-year net income growth rate
Latest
-38.48%
↓ 275% below average
Average (39q)
-10.27%
Historical baseline
Range
High:33.04%
Low:-87.89%
CAGR
+4.3%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -38.48% |
| Q2 2025 | -43.68% |
| Q1 2025 | -28.83% |
| Q4 2024 | -42.01% |
| Q3 2024 | -12.09% |
| Q2 2024 | 18.67% |
| Q1 2024 | -11.18% |
| Q4 2023 | -9.19% |
| Q3 2023 | -17.21% |
| Q2 2023 | 1.57% |
| Q1 2023 | 0.14% |
| Q4 2022 | -24.00% |
| Q3 2022 | 9.52% |
| Q2 2022 | -8.25% |
| Q1 2022 | -30.33% |
| Q4 2021 | 6.70% |
| Q3 2021 | 13.90% |
| Q2 2021 | -9.79% |
| Q1 2021 | -27.97% |
| Q4 2020 | -17.87% |
| Q3 2020 | 2.97% |
| Q2 2020 | 1.19% |
| Q1 2020 | -30.03% |
| Q4 2019 | -29.99% |
| Q3 2019 | 25.32% |
| Q2 2019 | -55.85% |
| Q1 2019 | 6.03% |
| Q4 2018 | 20.61% |
| Q3 2018 | 1.08% |
| Q2 2018 | -87.89% |
| Q1 2018 | 13.06% |
| Q4 2017 | 33.04% |
| Q3 2017 | -17.94% |
| Q2 2017 | 0.96% |
| Q1 2017 | -43.28% |
| Q4 2016 | 4.28% |
| Q3 2016 | -3.10% |
| Q2 2016 | -2.95% |
| Q1 2016 | 29.54% |
| Q4 2015 | -7.48% |